| Financial Year |
March 31 2023 |
| Monetary Funds |
466,531,544.67 |
| Held-for-trading Financial Assets |
221,923,168.00 |
| Notes Receivable |
40,324,552.84 |
| Accounts Receivable |
566,989,007.54 |
| Advances to Suppliers |
29,195,921.19 |
| Other Receivables |
26,618,125.92 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
269,050,026.21 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,936,101.19 |
| Total Current Assets |
1,768,333,332.97 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
92,293,107.56 |
| Investment Properties |
-- |
| Fixed Assetes |
955,922,468.23 |
| Under-construction Projects |
23,668,299.59 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
180,523,119.56 |
| R&D expenses |
9,394,090.07 |
| Goodwill |
262,659,090.97 |
| Long-Term Deferred and Prepaid Expenses |
4,410,520.92 |
| Deferred Income Tax Assets |
22,462,919.44 |
| Other Non-Current Assets |
28,602,824.13 |
| Sub-Total of Non-Current Assets |
1,609,799,988.73 |
| Total Assets |
3,378,133,321.70 |
| Short-Term Loans |
140,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
24,319,463.96 |
| Accounts Payable |
175,564,023.13 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
23,116,754.04 |
| Taxes Payable |
7,369,749.08 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
31,877,907.55 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,451,813.06 |
| Other Current Liabilities |
80,432,281.23 |
| Sub-Total of Current Liabilities |
518,207,480.68 |
| Long-term Loans |
49,700,000.00 |
| Bonds Payable |
416,801,277.77 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
23,284,922.97 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
577,624,623.16 |
| Total Liabilities |
1,095,832,103.84 |
| Paid-In Capital(Or Share Stock) |
1,021,602,247.00 |
| Capital Surplus |
218,389,745.26 |
| Surplus Reserve |
115,561,767.22 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
782,541,228.99 |
| Minority Stockholder's Interest |
47,410,394.78 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,234,890,823.08 |
| Owner's Equity（Stockholder's Equity） |
2,282,301,217.86 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,378,133,321.70 |
